Clinical trial
Utility of Lung Clearance Index Score as a Noninvasive Marker of Small Airways Disease
NCT03241420 is registered in ClinicalTrials.gov with National Jewish Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Utility of Lung Clearance Index Score as a Noninvasive Marker of Small Airways Disease
- Lead sponsor
- National Jewish Health
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- April 24, 2017
- Completion date
- December 31, 2030
- Enrollment
- 600 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic lung disease